Salipro Biotech is looking forward to meeting with partners at the BIO International Convention in this year’s digital format. Collaboration is more important than ever, and we at Salipro Biotech are committed to combating unmet medical needs.
Antibiotic resistance in bacteria: New research out using Salipro® and DARPin®. Congrats to the Ben Luisi lab at the University of Cambridge for solving the high-resolution cryoEM structure of a bacterial multidrug transporter and its allosteric modulation.
Salipro Biotech is looking forward to meeting with partners at the COVID-19 Virtual Partnering Event and accelerating the discovery of new therapeutics against COVID-19.
The Salipro platform enables the development of drugs against full-length SARS-CoV-2 (S, M or E) or host (ACE2, immune signaling receptors, etc.) membrane proteins.
Salipro® and snake venom enabled researchers at UT Southwestern Medical Center to solve a high-resolution structure of the AChR muscle protein. Find out more about lipids, toxins and the permeation pathway in the recent publication by Ryan Hibbs and colleagues: Link to publication
Salipro Biotech and Bicycle Therapeutics jointly announce results from their collaboration on a wild-type GPCR drug target. Results have just been published in Frontiers in Bioengineering and Biotechnology: “DirectMX – One-Step Reconstitution of Membrane Proteins From Crude Cell Membranes Into Salipro Nanoparticles”.
Link to article: https://www.frontiersin.org/articles/10.3389/fbioe.2020.00215/full
Salipro Biotech's Maria Lisa Knudsen pitches at SwedenBIO's Shark Tank, as part of their executive dinner event. Two sharks, Carolin Wiken at Paues Åberg Communications and Carl Kilander at HealthCap, decided to "invest" in us, meaning we will be receiving coaching from them.
Cambridge calling, Part 2! Salipro Biotech’s Robin Löving will be speaking at the 6th RSC / SCI Ion Channels as Therapeutic Targets symposium, Feb. 24-25. Robin will be sharing some of Salipro Biotech’s latest data generated with our pharma collaborators.
Cambridge calling, Part 1! Salipro Biotech’s Maria L. Knudsen is an invited speaker at Abzena’s 2nd Biopharmaceutical Discovery & Development Symposium on February 19th. Maria will be presenting data from our pharma collaborators on using the Salipro platform for antibody development. http://bit.ly/Abzenas2nd
Salipro will be live - Join us for a webinar: Our CSO Robin Löving has been invited to present how the Salipro platform can enable antibody discovery against challenging membrane proteins at the webinar “Discovery & Clinical Collaborations In Biotherapeutics”, organized by Oxford Global Conferences.
When: 29th January 2020, 4pm GMT (UK time)
To register/join: Click here.
Lisbon calling - wild-type GPCRs and more: Our CEO Jens Frauenfeld is invited speaker at #PEGS, presenting new data on the the direct membrane extraction (DirectMX) of membrane proteins.